Published in Hepatitis Weekly, May 17th, 2004
In the transaction, Genelabs sold all of the outstanding common and preferred stock of Genelabs Asia Pte., Ltd., (GLA) to MP Biomedicals. Prior to the sale, GLA, the parent company of Genelabs Diagnostics Pte., Ltd., (GLD) was a wholly owned subsidiary of Genelabs Technologies. GLD is a Singapore-based company that develops, manufactures, and markets diagnostics products primarily in Europe and Asia.
"The divestment of our diagnostics operations reinforces our intention to maintain a sharp focus on our core drug-discovery and -development...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.